LTRN
LTRN
US51654W1018
Lantern Pharma Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
17.978.494 22.216.437
19.1%
Operating Income -17.978.494 -22.216.437
19.1%
Pretax Income -17.119.438 -20.781.213
17.6%
Net Income Common Stockholders -17.119.438 -20.781.213
17.6%
-- --
--
-- --
--
ende